| Literature DB >> 31061170 |
Priya Chatterji1, Patrick A Williams2, Kelly A Whelan3,4, Fernando C Samper5,6, Sarah F Andres1, Lauren A Simon2, Louis R Parham2, Rei Mizuno1, Emma T Lundsmith7, David Sm Lee8, Shun Liang9, Hr Sagara Wijeratne9, Stefanie Marti4,5, Lillian Chau1, Veronique Giroux10, Benjamin J Wilkins11, Gary D Wu1, Premal Shah9,12, Gian G Tartaglia5,6,13, Kathryn E Hamilton14.
Abstract
RNA binding proteins, including IMP1/IGF2BP1, are essential regulators of intestinal development and cancer. Imp1 hypomorphic mice exhibit gastrointestinal growth defects, yet the specific role for IMP1 in colon epithelial repair is unclear. Our prior work revealed that intestinal epithelial cell-specific Imp1 deletion (Imp1 Δ IEC ) was associated with better regeneration in mice after irradiation. Here, we report increased IMP1 expression in patients with Crohn's disease and ulcerative colitis. We demonstrate that Imp1 Δ IEC mice exhibit enhanced recovery following dextran sodium sulfate (DSS)-mediated colonic injury. Imp1 Δ IEC mice exhibit Paneth cell granule changes, increased autophagy flux, and upregulation of Atg5. In silico and biochemical analyses revealed direct binding of IMP1 to MAP1LC3B, ATG3, and ATG5 transcripts. Genetic deletion of essential autophagy gene Atg7 in Imp1 Δ IEC mice revealed increased sensitivity of double-mutant mice to colonic injury compared to control or Atg7 single mutant mice, suggesting a compensatory relationship between Imp1 and the autophagy pathway. The present study defines a novel interplay between IMP1 and autophagy, where IMP1 may be transiently induced during damage to modulate colonic epithelial cell responses to damage.Entities:
Keywords: IGF2BP1; IMP1; RNA binding protein; colonic repair; inflammatory bowel disease
Mesh:
Substances:
Year: 2019 PMID: 31061170 PMCID: PMC6549032 DOI: 10.15252/embr.201847074
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807